Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.09 0.28 −1.52%
Market cap
$382.4M
P/E
0.0×
Fwd P/E
−8.4×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+5 more TTM periods

0.00% 0.00% (112.55%) (151.89%)
ROA
(41.23%) (47.51%) (54.97%) (30.49%)
ROIC
(53.36%) (52.42%) (49.09%) (54.72%)
Return on Tangible Assets
(22.56%) (25.95%) (29.80%) (25.19%)
Average Days of Receivables
64.03 63.78 71.42 66.08
Free Cash Flow per Share
(2.15) (4.15) (2.12) (2.27)
Free Cash Flow
(29.27) (36.02) (43.79) (47.08)
Capital Expenditures
(6.17) (7.41) (9.30) (9.99)
Other line items
Cash ROIC
(9.76%) (12.87%) (17.07%) (19.77%)
Accounts Receivable Turnover
0.00 0.00 6.88 6.76
Accounts Payable Turnover
0.00 0.00 2.32 2.27
Inventory Turnover
0.00 0.00 0.70 0.68
Average Days of Payables
340.74 291.41 173.04 159.06
Days of Inventory on Hand
743.05 709.02 637.61 614.68
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
13.89% 16.34% 18.37% 19.79%
Selling, General and Administrative Expense of Revenue
116.27% 115.75% 115.92% 116.08%
Share Based Compensation of Revenue
2.11% 2.10% 2.96% 4.14%
Interest Coverage
(22.19) (375.67) 42.26 21.67
Operating CF/Net income
0.63 0.71 0.78 1.06
Depreciation/Fixed assets
0.29 0.28 0.27 0.30
Capex/Depreciation
(1.97) (2.14) (2.38) (2.31)
Revenue per Share
2.97 5.46 2.61 2.90
Operating CF per Share
(1.70) (3.30) (1.67) (1.79)
Capex per Share
(0.45) (0.85) (0.45) (0.48)
Capex to Sales
0.15 0.16 0.17 0.17

Fold the line items

Columns are period end dates